News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Press Releases
Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search
here.
THE LATEST
Press Releases
Hairy Cell Leukemia Market to Surpass USD 223.3 Million in 2032, Driven by Rising Cases of Rare Hematologic Cancers | Coherent Market Insights
July 17, 2025
·
1 min read
Press Releases
NervGen Announces Leadership Transition to Support Strategic Growth and Expansion
Chairman Dr. Adam Rogers Appointed Interim CEO Following Landmark Positive Chronic Spinal Cord Injury Trial Results
July 17, 2025
·
7 min read
Press Releases
Maxwell Biosciences Announces AI Department & Hiring of Jon McClure
New leadership to spearhead AI-driven breakthroughs in drug discovery and operational excellence
July 17, 2025
·
4 min read
Press Releases
ENHERTU® Plus Pertuzumab Granted Breakthrough Therapy Designation in the U.S. as First-Line Therapy for Patients with HER2 Positive Metastatic Breast Cancer
July 17, 2025
·
19 min read
Press Releases
Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering
July 17, 2025
·
1 min read
Press Releases
Cycle Pharmaceuticals launches HARLIKU™ (nitisinone) Tablets, the first FDA-approved treatment for use in Alkaptonuria (AKU)
July 17, 2025
·
5 min read
Press Releases
Machine Learning in Drug Discovery Market to Witness Exponential Growth: Key Players, $250M Eli Lilly Deal & Regional Insights for 2025-2034
July 17, 2025
·
1 min read
Press Releases
Antibody Discovery Market Size to Surpass USD 20.4 Bn by 2034 Fueled by Precision Medicine and Biotech Innovation
July 17, 2025
·
1 min read
Press Releases
TriHaz Solutions Opens New Clarksville, TN Facility to Expand Regulated Medical Waste Services Across Tennessee
July 17, 2025
·
1 min read
Press Releases
U.S. Allergy Diagnostics and Therapeutics Market Size to Hit USD 21.20 Billion by 2034
July 17, 2025
·
1 min read
Press Releases
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
July 17, 2025
·
13 min read
Press Releases
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
July 17, 2025
·
3 min read
Press Releases
Immuron - FY25 global sales exceed projection, up 49% on prior year
July 17, 2025
·
4 min read
Press Releases
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
July 17, 2025
·
21 min read
Press Releases
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025
·
12 min read
Press Releases
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
July 17, 2025
·
1 min read
Press Releases
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam
July 17, 2025
·
3 min read
Press Releases
Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call
July 17, 2025
·
1 min read
Press Releases
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach
July 17, 2025
·
8 min read
Press Releases
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - July 16, 2025
July 17, 2025
·
2 min read
Press Releases
Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment
July 17, 2025
·
2 min read
Press Releases
Cognition Therapeutics’ Positive Clinical Data from Zervimesine (CT1812) Phase 2 Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC
July 17, 2025
·
10 min read
Press Releases
Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s, Further Strengthening its Global Intellectual Property Portfolio
July 17, 2025
·
5 min read
Press Releases
CVRx Announces Positive News on Outpatient Payment for Barostim
July 17, 2025
·
3 min read
Press Releases
Zevra Therapeutics Announces Open Label Extension Data Showing Sustained Long-Term Efficacy of MIPLYFFA for the Treatment of NPC Published in the Journal of Molecular Genetics and Metabolism
July 17, 2025
·
7 min read
Press Releases
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics’ EsoGuard® Esophageal DNA Test
July 17, 2025
·
4 min read
Press Releases
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
July 17, 2025
·
8 min read
Press Releases
ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes
July 17, 2025
·
1 min read
Press Releases
Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra™ (Resmetirom)
July 17, 2025
·
4 min read
Press Releases
Cue Biopharma Reports New Complete Response and Confirmed 50% Overall Response Rate in Ongoing Phase 1 Trial of CUE-101 and Pembrolizumab in Recurrent/Metastatic HPV+ Head and Neck Cancer
July 17, 2025
·
7 min read
Press Releases
Qualigen Granted New Patents Covering 25 Countries
July 17, 2025
·
3 min read
Press Releases
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse
July 17, 2025
·
4 min read
Press Releases
SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer
July 17, 2025
·
2 min read
Press Releases
Bio-Thera Solutions Announces FDA Accepts Biologics License Application for BAT2506, a Proposed Biosimilar to Simponi®
July 17, 2025
·
7 min read